rs12721634

Variant names:

• chr7-99784038-A-G
• rs12721634
• NM_017460.6:c.44T>C

Your query was ambiguous. Multiple possible variants found:

• chr7-99784038-A-G
• chr7-99784038-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2 BP4 BP6

The NM_017460.6(CYP3A4):​c.44T>C​(p.Leu15Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in Lovd as Likely benign (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.

• Frequency: Genomes: not found (cov: 31)
• Consequence: CYP3A4 NM_017460.6 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 3.57

Genes affected

CYP3A4 (HGNC:2637): (cytochrome P450 family 3 subfamily A member 4) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020]

ACMG classification

Verdict is Uncertain_significance. Variant got 0 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.39314494).
• BP6: Variant 7-99784038-A-G is Benign according to our data. Variant chr7-99784038-A-G is described in Lovd as [Likely_benign].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CYP3A4	NM_017460.6	c.44T>C	p.Leu15Pro	missense_variant	Exon 1 of 13	ENST00000651514.1	NP_059488.2
CYP3A4	NM_001202855.3	c.44T>C	p.Leu15Pro	missense_variant	Exon 1 of 13		NP_001189784.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CYP3A4	ENST00000651514.1	c.44T>C	p.Leu15Pro	missense_variant	Exon 1 of 13		NM_017460.6	ENSP00000498939.1

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome Cov.: 30

GnomAD4 genome Cov.: 31

Alfa AF: 0.0000271 Hom.: 1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Uncertain	0.36
BayesDel_addAF	Uncertain	0.032	T
BayesDel_noAF	Benign	-0.19
CADD	Uncertain	25
DANN	Uncertain	1.0
DEOGEN2	Benign	0.014	T;D;T
Eigen	Uncertain	0.22
Eigen_PC	Benign	0.069
FATHMM_MKL	Benign	0.40	N
LIST_S2	Benign	0.34	T;D;D
M_CAP	Benign	0.0038	T
MetaRNN	Benign	0.39	T;T;T
MetaSVM	Benign	-1.1	T
MutationAssessor	Pathogenic	3.6	.;H;.
PrimateAI	Benign	0.46	T
PROVEAN	Benign	0.090	N;D;D
REVEL	Benign	0.14
Sift	Uncertain	0.0060	D;D;D
Sift4G	Uncertain	0.0060	D;D;.
Polyphen		0.98	D;D;.
Vest4		0.41
MutPred		0.24		Gain of catalytic residue at L15 (P = 0.0178);Gain of catalytic residue at L15 (P = 0.0178);Gain of catalytic residue at L15 (P = 0.0178);
MVP		0.56
MPC		0.57
ClinPred		0.95	D
GERP RS		3.9
Varity_R		0.83

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs12721634; hg19: chr7-99381661;